Dana M Brantley-Sieders

5PUBLICATIONS
18CO-AUTHORS
Te whakamahi me te hoahoa o te hangarau rorohiko o te Māori (Māori computing technology use and design)Molecular targetsTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 15, 2026
The impact of Susan G. Komen-funded research on approved drugs for breast cancer treatment.

Dana M Brantley-Sieders, Lauren Leslie, Kimberly Sabelko

|Feb 28, 2025
Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi Nanomedicine.

Shrusti S Patel, Rebecca S Cook, Justin H Lo

|Apr 19, 2021
EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease.

David B Vaught, Alyssa R Merkel, Conor C Lynch

|Mar 09, 2021
Oncogenic functions and therapeutic targeting of EphA2 in cancer.

Kalin Wilson, Eileen Shiuan, Dana M Brantley-Sieders

|Jun 10, 2020
Host deficiency in ephrin-A1 inhibits breast cancer metastasis.

Eileen Shiuan, Ashwin Inala, Shan Wang

Pageof 1